Medicine & Life Sciences
Acquired Immunodeficiency Syndrome
9%
Adenoviridae
48%
Adenovirus Vaccines
10%
AIC246
9%
Allografts
16%
Anti-Bacterial Agents
10%
Anti-Retroviral Agents
8%
Antiviral Agents
37%
Apoptosis
25%
Bacteremia
17%
Caspase 8
10%
Cell Death
14%
Chronic Hepatitis C
14%
Cohort Studies
11%
Communicable Diseases
12%
Community-Based Participatory Research
21%
Confidence Intervals
12%
Coronavirus
67%
Cryptococcosis
10%
Cytomegalovirus
85%
Cytomegalovirus Infections
48%
DNA
12%
Endocarditis
28%
Epidemiology
13%
Equipment and Supplies
27%
Feline Immunodeficiency Virus
8%
Fever
10%
Ganciclovir
16%
Genes
16%
Genetic Therapy
14%
GS-5734
8%
Health
9%
Heart
9%
Hematopoietic Stem Cell Transplantation
10%
Hematopoietic Stem Cells
12%
Heme Oxygenase-1
9%
Hepacivirus
25%
Herpesviridae Infections
9%
Highly Active Antiretroviral Therapy
8%
HIV
85%
HIV Infections
35%
HIV Protease Inhibitors
11%
HIV-1
39%
Hospitalization
13%
Human Adenoviruses
10%
Human Herpesvirus 6
23%
Human Herpesvirus 7
8%
Human Influenza
15%
Immunization
16%
Immunocompromised Host
15%
In Vitro Techniques
10%
Incidence
12%
Infections
80%
Invasive Fungal Infections
9%
Joints
14%
Kidney
17%
lens epithelium-derived growth factor
8%
Liver
12%
Liver Transplantation
44%
Lung
11%
Monoclonal Antibodies
15%
Morbidity
9%
Mortality
23%
Mycoses
14%
Nelfinavir
8%
Opportunistic Infections
22%
Organ Transplantation
31%
Pandemics
18%
Peptides
9%
Pharmaceutical Preparations
20%
Polymerase Chain Reaction
10%
Population
13%
Propionic Acidemia
14%
Protease Inhibitors
15%
Proteins
14%
Randomized Controlled Trials
9%
Refugees
16%
Retroviridae Infections
17%
Reverse Transcriptase Inhibitors
9%
Ribavirin
8%
Ritonavir
11%
Safety
11%
SARS Virus
37%
Serogroup
21%
Severe Acute Respiratory Syndrome
20%
Staphylococcus aureus
8%
T-Lymphocytes
41%
Therapeutics
40%
Tissue Donors
15%
Transplant Recipients
100%
Transplantation
22%
Transplants
59%
Tuberculosis
20%
Vaccination
23%
Vaccines
37%
Valganciclovir
11%
Viral Load
10%
Viremia
12%
Virus Diseases
35%
Viruses
33%